Envista Holdings Corp

Envista Holdings Corporation (NASDAQ: ENVG) operates as a global family of more than 30 trusted dental brands united by a shared purpose to partner with professionals and improve lives. The company's website is www.envistaco.com. Founded in 2018 as a wholly-owned subsidiary of Danaher Corporation, Envista completed its initial public offering and separated from Danaher in 2019, establishing itself as an independent publicly traded company.

The company generates total sales of approximately $2.7 billion, with roughly 85 percent derived from consumable products, services, and spare parts. Envista operates through two primary segments: Specialty Products & Technologies, representing 64 percent of revenue, and Equipment & Consumables, representing 36 percent of revenue. The Specialty Products & Technologies segment encompasses Dental Implant Solutions and Orthodontic Solutions businesses, featuring renowned brands including Nobel Biocare, Ormco, Damon, Insignia, and Spark clear aligners. The Equipment & Consumables segment comprises Diagnostic and Consumables Solutions businesses, offering digital imaging systems, endodontic products, restorative materials, and infection prevention solutions under brands such as DEXIS, Kerr, and Metrex.

Envista serves dental professionals in over 130 countries through one of the largest commercial organizations in the dental products industry, employing approximately 12,000 people globally, with roughly 3,000 in the United States and 9,000 internationally. The company maintains a diverse geographic footprint, generating 51 percent of sales from North America, 23 percent from Western Europe, 22 percent from emerging markets, and 4 percent from other developed markets. Approximately 42 percent of products are distributed through third-party distributors, with Henry Schein representing approximately 12 percent of sales.

The company's competitive strengths include a premier portfolio with leadership in attractive segments, a proven track record of innovation, the proprietary Envista Business System methodology, strong brand recognition, global commercial reach, and a significant position in emerging markets. Envista maintains over 1,500 granted patents protecting its products and technologies. The company is positioned as one of the largest global dental products companies, serving dental specialists, general dentists, dental laboratories, and dental service organizations worldwide.